Drug Shortage Report for HYDROXYZINE
| Report ID | 265986 |
| Drug Identification Number | 00646016 |
| Brand name | HYDROXYZINE |
| Common or Proper name | HYDROXYZINE |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROXYZINE HYDROCHLORIDE |
| Strength(s) | 50MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BTL |
| ATC code | N05BB |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-08-26 |
| Actual start date | |
| Estimated end date | 2025-09-18 |
| Actual end date | 2025-09-16 |
| Shortage status | Resolved |
| Updated date | 2025-09-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-09-17 | French | Compare |
| v5 | 2025-09-17 | English | Compare |
| v4 | 2025-09-10 | French | Compare |
| v3 | 2025-09-10 | English | Compare |
| v2 | 2025-08-27 | French | Compare |
| v1 | 2025-08-27 | English | Compare |
Showing 1 to 6 of 6